Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Lava Therapeutics
Lava Therapeutics
Seagen, amid deal rumors, spends $50M on a dual-targeting cancer drug
Seagen, amid deal rumors, spends $50M on a dual-targeting cancer drug
BioPharma Dive
Seagen
Merck
Lava Therapeutics
bispecific antibodies
LAVA-1223
Flag link:
